Last reviewed · How we verify
NCT07012759
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
trial testing biomarkers in Biomarkers in 100 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Fu Jen Catholic University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 10 June 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- biomarkers — full drug profile →
Conditions studied
- Biomarkers — all drugs for Biomarkers →
- Lung Adenocarcinoma — all drugs for Lung Adenocarcinoma →
- Pleural Effusion — all drugs for Pleural Effusion →
Sponsor
Fu Jen Catholic University
Who can join
18 and older, any sex, with Biomarkers or Lung Adenocarcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07012759
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of biomarkers
Trials testing the same drug.
- NCT06218654 — Hemodynamic Instability of Patient With Spontaneous Subarachnoid Hemorrhage · recruiting
- NCT06187324 — Accuracy of Host-derived Biomarkers in Diagnosing Symptomatic and Asymptomatic Apical Periodontitis · NA · unknown
- NCT07480187 — Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices · NA · active not recruiting
- NCT06711952 — German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q) · NA · recruiting
- NCT04674605 — A Prospective Cohort Study Of Myasthenia Gravis · unknown
Other recruiting trials for Biomarkers
Currently open trials in the same condition.
- NCT06717243 — Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS) · recruiting
- NCT06924372 — Application of Salivary Biomarkers in Risk Assessment for Oral Diseases in Children With Type 1 Diabetes · active not recruiting
- NCT07345286 — Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC · recruiting
- NCT06751251 — The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determi · active not recruiting
- NCT06944457 — Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor · Phase 1 · recruiting
Other Fu Jen Catholic University trials
Trials by the same sponsor.
- NCT07474220 — Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease · not yet recruiting
- NCT07445035 — Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation · NA · not yet recruiting
- NCT07497932 — Nutritional Effects in Cardiovascular Surgery · NA · recruiting
- NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
- NCT07447232 — Comparing Ultrasonic and Conventional Spirometry in Chronic Respiratory Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07012759 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fu Jen Catholic University
- Last refreshed: 5 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07012759.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing